Gene Symbol | Gene ID | Gene Info |
---|---|---|
Maz
|
ENSMUSG00000030678.6 | MYC-associated zinc finger protein (purine-binding transcription factor) |
Zfp281
|
ENSMUSG00000041483.8 | zinc finger protein 281 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_127026179_127026503 | Maz | 111 | 0.865920 | -0.74 | 9.6e-11 | Click! |
chr7_127026546_127028177 | Maz | 324 | 0.579988 | -0.68 | 1.3e-08 | Click! |
chr7_127024852_127025021 | Maz | 196 | 0.793433 | -0.66 | 3.8e-08 | Click! |
chr7_127025132_127025773 | Maz | 320 | 0.654725 | -0.62 | 4.3e-07 | Click! |
chr7_127025833_127026048 | Maz | 512 | 0.459884 | -0.61 | 6.5e-07 | Click! |
chr1_136629161_136629312 | Zfp281 | 4335 | 0.143794 | -0.53 | 3.4e-05 | Click! |
chr1_136629463_136629614 | Zfp281 | 4637 | 0.141146 | -0.35 | 8.5e-03 | Click! |
chr1_136625347_136625639 | Zfp281 | 592 | 0.495199 | 0.26 | 5.6e-02 | Click! |
chr1_136624602_136624997 | Zfp281 | 102 | 0.560874 | 0.16 | 2.5e-01 | Click! |
chr1_136625136_136625288 | Zfp281 | 311 | 0.654132 | 0.11 | 4.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_3236518_3237725 | 143.57 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr19_61225302_61226760 | 128.51 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr16_16561093_16561486 | 123.56 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
1070 |
0.53 |
chr10_81429712_81431957 | 102.04 |
Nfic |
nuclear factor I/C |
171 |
0.85 |
chr2_33130296_33131698 | 101.22 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr16_44687184_44688343 | 90.95 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr10_81559146_81561402 | 89.43 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr2_94273064_94274137 | 76.02 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr7_44310178_44311500 | 73.46 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chr10_81472309_81472908 | 72.42 |
Celf5 |
CUGBP, Elav-like family member 5 |
394 |
0.64 |
chr19_38054215_38055320 | 71.43 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr2_17730264_17731671 | 66.15 |
Nebl |
nebulette |
76 |
0.98 |
chr9_86879639_86880662 | 64.64 |
Snap91 |
synaptosomal-associated protein 91 |
247 |
0.94 |
chrX_13346707_13347908 | 63.91 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr1_93176328_93177269 | 63.74 |
Crocc2 |
ciliary rootlet coiled-coil, rootletin family member 2 |
8073 |
0.13 |
chr2_127521161_127522051 | 56.18 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr15_78835129_78836581 | 53.96 |
Cdc42ep1 |
CDC42 effector protein (Rho GTPase binding) 1 |
6769 |
0.09 |
chr7_31127074_31128340 | 53.16 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr14_6037512_6038662 | 52.74 |
Gm8206 |
predicted gene 8206 |
122 |
0.93 |
chr5_37028527_37029187 | 52.57 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
255 |
0.91 |
chr2_102451171_102452295 | 51.64 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr1_132880253_132881745 | 51.38 |
Lrrn2 |
leucine rich repeat protein 2, neuronal |
644 |
0.72 |
chr14_4018192_4019443 | 51.12 |
Gm5796 |
predicted gene 5796 |
5124 |
0.14 |
chr7_19094759_19096427 | 51.03 |
Six5 |
sine oculis-related homeobox 5 |
999 |
0.28 |
chr1_3671269_3672324 | 50.99 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr8_12873206_12874084 | 50.75 |
Mcf2l |
mcf.2 transforming sequence-like |
161 |
0.92 |
chr14_6756349_6757421 | 50.60 |
Gm3636 |
predicted gene 3636 |
14553 |
0.14 |
chr9_122571793_122572853 | 50.40 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
176 |
0.93 |
chr14_14345884_14346978 | 50.06 |
Il3ra |
interleukin 3 receptor, alpha chain |
1 |
0.93 |
chr14_7314343_7315443 | 49.98 |
Gm3739 |
predicted gene 3739 |
156 |
0.94 |
chr2_126932364_126933545 | 49.19 |
Sppl2a |
signal peptide peptidase like 2A |
281 |
0.9 |
chr8_122284023_122284944 | 48.99 |
Zfpm1 |
zinc finger protein, multitype 1 |
2342 |
0.24 |
chr13_96132470_96133258 | 48.90 |
Sv2c |
synaptic vesicle glycoprotein 2c |
287 |
0.67 |
chr14_4334095_4335404 | 48.26 |
2610042L04Rik |
RIKEN cDNA 2610042L04 gene |
14 |
0.97 |
chr15_40654880_40655719 | 47.51 |
Zfpm2 |
zinc finger protein, multitype 2 |
52 |
0.99 |
chr14_4726126_4727100 | 47.30 |
Gm3252 |
predicted gene 3252 |
162 |
0.93 |
chr14_4110111_4111235 | 46.90 |
Gm8108 |
predicted gene 8108 |
147 |
0.94 |
chr10_81473166_81473568 | 46.13 |
Celf5 |
CUGBP, Elav-like family member 5 |
11 |
0.93 |
chr15_89453930_89454500 | 46.06 |
Mapk8ip2 |
mitogen-activated protein kinase 8 interacting protein 2 |
302 |
0.77 |
chr7_16129395_16130325 | 45.90 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
34 |
0.96 |
chr18_58209878_58210987 | 45.11 |
Fbn2 |
fibrillin 2 |
55 |
0.98 |
chr2_173658978_173659962 | 45.07 |
Ppp4r1l-ps |
protein phosphatase 4, regulatory subunit 1-like, pseudogene |
34 |
0.8 |
chr14_3948585_3949537 | 44.85 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr3_73056881_73057482 | 44.83 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
238 |
0.92 |
chr11_97699300_97700660 | 44.51 |
Pcgf2 |
polycomb group ring finger 2 |
332 |
0.72 |
chr14_7488010_7488824 | 44.38 |
Gm3752 |
predicted gene 3752 |
4655 |
0.16 |
chr14_7244047_7245236 | 44.19 |
Gm5456 |
predicted gene 5456 |
3199 |
0.18 |
chr6_136173009_136173858 | 43.81 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
56 |
0.85 |
chr15_103339347_103340247 | 43.56 |
Zfp385a |
zinc finger protein 385A |
296 |
0.82 |
chr2_132029196_132030408 | 42.79 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
199 |
0.94 |
chr8_123514747_123515742 | 42.55 |
Dbndd1 |
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
146 |
0.78 |
chr4_22488420_22489023 | 42.39 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
355 |
0.83 |
chr7_4995595_4996371 | 42.38 |
Zfp579 |
zinc finger protein 579 |
46 |
0.92 |
chr16_44632721_44633371 | 42.21 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
74149 |
0.08 |
chr2_105680597_105681214 | 41.99 |
Pax6 |
paired box 6 |
807 |
0.59 |
chr7_57590461_57591180 | 41.98 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
302 |
0.92 |
chr19_10413660_10414496 | 41.87 |
Syt7 |
synaptotagmin VII |
10060 |
0.14 |
chr9_49796724_49798126 | 41.86 |
Ncam1 |
neural cell adhesion molecule 1 |
1333 |
0.53 |
chr3_114029993_114030781 | 41.85 |
Col11a1 |
collagen, type XI, alpha 1 |
153 |
0.98 |
chr17_47832392_47833559 | 41.80 |
Mdfi |
MyoD family inhibitor |
194 |
0.91 |
chr8_12915219_12915955 | 41.33 |
Gm15351 |
predicted gene 15351 |
32 |
0.8 |
chr3_89182983_89184019 | 41.21 |
Fam189b |
family with sequence similarity 189, member B |
79 |
0.89 |
chr13_55487049_55488117 | 41.16 |
Dbn1 |
drebrin 1 |
50 |
0.94 |
chr5_112577448_112578314 | 41.15 |
Sez6l |
seizure related 6 homolog like |
696 |
0.62 |
chr3_127698278_127698609 | 41.04 |
Gm16238 |
predicted gene 16238 |
5923 |
0.12 |
chr11_80080470_80081713 | 40.45 |
Crlf3 |
cytokine receptor-like factor 3 |
100 |
0.96 |
chr1_89183290_89183867 | 40.23 |
Gm5259 |
predicted gene 5259 |
73403 |
0.09 |
chr14_3332417_3333262 | 40.07 |
Gm2956 |
predicted gene 2956 |
212 |
0.91 |
chr11_98963166_98964309 | 39.94 |
Rara |
retinoic acid receptor, alpha |
3325 |
0.14 |
chr12_111758304_111760062 | 39.78 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr14_6889264_6890534 | 39.75 |
Gm3667 |
predicted gene 3667 |
63 |
0.97 |
chr18_21653019_21653700 | 39.66 |
4930426D05Rik |
RIKEN cDNA 4930426D05 gene |
796 |
0.5 |
chr19_6497572_6498241 | 39.41 |
Nrxn2 |
neurexin II |
71 |
0.96 |
chr3_89315223_89316179 | 39.35 |
Gm15998 |
predicted gene 15998 |
262 |
0.77 |
chr14_3412209_3412992 | 39.32 |
Gm10409 |
predicted gene 10409 |
14 |
0.96 |
chr8_4206127_4207837 | 39.27 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr17_37049946_37051278 | 39.16 |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
19 |
0.95 |
chr13_18947816_18948472 | 38.96 |
Amph |
amphiphysin |
61 |
0.97 |
chr14_3208167_3209194 | 38.55 |
D830030K20Rik |
RIKEN cDNA D830030K20 gene |
103 |
0.95 |
chr3_89391710_89392572 | 38.53 |
Zbtb7b |
zinc finger and BTB domain containing 7B |
72 |
0.62 |
chr6_29434887_29435275 | 38.34 |
Flnc |
filamin C, gamma |
1805 |
0.2 |
chr9_106452968_106454846 | 38.18 |
Pcbp4 |
poly(rC) binding protein 4 |
8 |
0.92 |
chr1_92831123_92832495 | 38.16 |
Gpc1 |
glypican 1 |
160 |
0.92 |
chr10_79613505_79614566 | 38.12 |
C2cd4c |
C2 calcium-dependent domain containing 4C |
10 |
0.95 |
chr9_124439906_124440949 | 38.00 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr4_136835920_136836937 | 37.80 |
Ephb2 |
Eph receptor B2 |
440 |
0.83 |
chr9_20726843_20728134 | 37.62 |
Olfm2 |
olfactomedin 2 |
551 |
0.72 |
chr2_84742105_84743284 | 37.58 |
Gm19426 |
predicted gene, 19426 |
961 |
0.29 |
chr11_98959522_98960759 | 37.57 |
Rara |
retinoic acid receptor, alpha |
272 |
0.84 |
chr19_42431698_42432696 | 37.50 |
Crtac1 |
cartilage acidic protein 1 |
412 |
0.84 |
chr2_151701768_151703133 | 37.41 |
Tmem74b |
transmembrane protein 74B |
139 |
0.92 |
chr9_119980991_119982157 | 37.27 |
Csrnp1 |
cysteine-serine-rich nuclear protein 1 |
1449 |
0.22 |
chr7_79578006_79578675 | 37.17 |
Gm45168 |
predicted gene 45168 |
728 |
0.49 |
chr8_93809858_93810893 | 37.05 |
4930488L21Rik |
RIKEN cDNA 4930488L21 gene |
85 |
0.74 |
chrX_151169253_151169662 | 36.67 |
Gm15138 |
predicted gene 15138 |
243 |
0.89 |
chr7_43490136_43490673 | 36.55 |
Iglon5 |
IgLON family member 5 |
329 |
0.72 |
chr9_65178677_65179325 | 36.52 |
Igdcc3 |
immunoglobulin superfamily, DCC subclass, member 3 |
1737 |
0.25 |
chr14_6426499_6427300 | 36.12 |
Lamtor3-ps |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3, pseudogene |
14417 |
0.14 |
chr16_18629072_18630255 | 35.98 |
Septin5 |
septin 5 |
41 |
0.96 |
chr2_157464727_157465479 | 35.97 |
Src |
Rous sarcoma oncogene |
8018 |
0.18 |
chr9_16501284_16502590 | 35.86 |
Fat3 |
FAT atypical cadherin 3 |
652 |
0.82 |
chr14_5070417_5071423 | 35.65 |
Gm8281 |
predicted gene, 8281 |
120 |
0.95 |
chr14_34819764_34820558 | 35.65 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
53 |
0.98 |
chr8_84701108_84701942 | 35.51 |
Lyl1 |
lymphoblastomic leukemia 1 |
19 |
0.95 |
chr15_26308701_26309304 | 35.47 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
46 |
0.99 |
chrX_103252121_103252497 | 35.19 |
4930519F16Rik |
RIKEN cDNA 4930519F16 gene |
738 |
0.51 |
chr2_30692579_30693130 | 35.19 |
Gm14486 |
predicted gene 14486 |
14843 |
0.14 |
chr14_6287027_6287952 | 35.15 |
Gm3411 |
predicted gene 3411 |
239 |
0.89 |
chr11_112869991_112870994 | 35.14 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
45313 |
0.16 |
chr7_44427795_44428672 | 35.05 |
Lrrc4b |
leucine rich repeat containing 4B |
785 |
0.39 |
chr1_74103754_74104304 | 35.02 |
Tns1 |
tensin 1 |
5353 |
0.18 |
chr6_121473518_121474161 | 34.96 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
161 |
0.96 |
chr7_84409236_84410328 | 34.81 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
101 |
0.96 |
chr14_5961062_5962084 | 34.77 |
Gm3248 |
predicted gene 3248 |
172 |
0.91 |
chr5_116591724_116592384 | 34.72 |
Srrm4 |
serine/arginine repetitive matrix 4 |
237 |
0.93 |
chr2_3117961_3119194 | 34.62 |
Fam171a1 |
family with sequence similarity 171, member A1 |
108 |
0.97 |
chr6_72188837_72189690 | 34.55 |
Gm38832 |
predicted gene, 38832 |
26414 |
0.13 |
chr13_109116814_109117670 | 34.42 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
601 |
0.86 |
chr14_3809454_3810456 | 34.40 |
Gm3002 |
predicted gene 3002 |
119 |
0.95 |
chrX_73715848_73717161 | 34.39 |
Abcd1 |
ATP-binding cassette, sub-family D (ALD), member 1 |
93 |
0.77 |
chr5_53212724_53213735 | 34.35 |
Sel1l3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
86 |
0.97 |
chr18_12643212_12644484 | 34.26 |
Ttc39c |
tetratricopeptide repeat domain 39C |
486 |
0.46 |
chr14_31205580_31207467 | 34.16 |
Nisch |
nischarin |
177 |
0.89 |
chr5_19226220_19227454 | 33.99 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
199 |
0.6 |
chrX_150656289_150656688 | 33.94 |
Tro |
trophinin |
560 |
0.72 |
chr1_176274926_176275827 | 33.90 |
Pld5 |
phospholipase D family, member 5 |
64 |
0.94 |
chr15_18818564_18819019 | 33.88 |
C030047K22Rik |
RIKEN cDNA C030047K22 gene |
17 |
0.67 |
chr2_93187957_93189155 | 33.73 |
Trp53i11 |
transformation related protein 53 inducible protein 11 |
635 |
0.76 |
chr16_33605736_33606716 | 33.66 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr13_78200366_78200817 | 33.62 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
813 |
0.37 |
chr5_109556763_109557843 | 33.60 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr7_45784749_45786509 | 33.56 |
Lmtk3 |
lemur tyrosine kinase 3 |
119 |
0.87 |
chr17_37045564_37046927 | 33.51 |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
46 |
0.94 |
chr2_32317120_32318698 | 33.49 |
Gm23363 |
predicted gene, 23363 |
356 |
0.45 |
chr15_99456957_99458276 | 33.48 |
Nckap5l |
NCK-associated protein 5-like |
96 |
0.93 |
chr9_56868158_56868636 | 33.46 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
3364 |
0.16 |
chr14_4181957_4182899 | 33.39 |
Gm2974 |
predicted gene 2974 |
148 |
0.94 |
chr1_74284190_74285456 | 33.37 |
Aamp |
angio-associated migratory protein |
85 |
0.51 |
chr9_37359459_37360109 | 33.37 |
Hepacam |
hepatocyte cell adhesion molecule |
7567 |
0.11 |
chr14_18893044_18894412 | 33.19 |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
10 |
0.98 |
chr7_79535477_79536145 | 33.06 |
Gm35040 |
predicted gene, 35040 |
232 |
0.85 |
chr4_23982818_23983489 | 33.01 |
Gm28448 |
predicted gene 28448 |
49199 |
0.19 |
chrX_106485268_106485878 | 32.93 |
Fndc3c1 |
fibronectin type III domain containing 3C1 |
172 |
0.95 |
chr10_83722468_83723424 | 32.87 |
1500009L16Rik |
RIKEN cDNA 1500009L16 gene |
20 |
0.98 |
chr17_46629306_46630520 | 32.84 |
Ptk7 |
PTK7 protein tyrosine kinase 7 |
409 |
0.72 |
chr5_24482511_24483721 | 32.79 |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
2944 |
0.12 |
chr5_23675895_23676511 | 32.78 |
Srpk2 |
serine/arginine-rich protein specific kinase 2 |
152 |
0.84 |
chr1_79858099_79859256 | 32.77 |
Serpine2 |
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
19 |
0.98 |
chr17_25433917_25434633 | 32.72 |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
492 |
0.69 |
chr2_65022121_65023287 | 32.63 |
Grb14 |
growth factor receptor bound protein 14 |
78 |
0.98 |
chr10_118102987_118104071 | 32.61 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
8988 |
0.17 |
chr10_127620769_127621196 | 32.57 |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
12 |
0.95 |
chr6_107529484_107530270 | 32.56 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
109 |
0.97 |
chr13_74639270_74640542 | 32.53 |
Erap1 |
endoplasmic reticulum aminopeptidase 1 |
33 |
0.97 |
chr18_37143396_37144041 | 32.49 |
Pcdhac2 |
protocadherin alpha subfamily C, 2 |
215 |
0.89 |
chr8_9771269_9772260 | 32.48 |
Fam155a |
family with sequence similarity 155, member A |
603 |
0.53 |
chr14_66910808_66911486 | 32.45 |
Pnma2 |
paraneoplastic antigen MA2 |
23 |
0.97 |
chrX_166344291_166344543 | 32.41 |
Gpm6b |
glycoprotein m6b |
275 |
0.93 |
chr7_81454347_81455042 | 32.37 |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
19 |
0.95 |
chr7_105787328_105788039 | 32.28 |
Dchs1 |
dachsous cadherin related 1 |
29 |
0.95 |
chr15_25754647_25755340 | 32.26 |
Myo10 |
myosin X |
2014 |
0.38 |
chr14_58075802_58076610 | 32.23 |
Fgf9 |
fibroblast growth factor 9 |
301 |
0.9 |
chr16_41532566_41532885 | 32.22 |
Lsamp |
limbic system-associated membrane protein |
133 |
0.98 |
chr3_52102146_52103076 | 32.11 |
Maml3 |
mastermind like transcriptional coactivator 3 |
2465 |
0.23 |
chr8_84742133_84743295 | 32.07 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
19707 |
0.09 |
chr14_5000842_5001422 | 32.05 |
Gm3298 |
predicted gene 3298 |
14759 |
0.13 |
chr19_36553934_36555231 | 32.01 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr11_51855495_51856955 | 31.99 |
Jade2 |
jade family PHD finger 2 |
900 |
0.57 |
chr3_88205532_88206477 | 31.93 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr7_73375251_73375992 | 31.89 |
Rgma |
repulsive guidance molecule family member A |
101 |
0.56 |
chr17_4907788_4908541 | 31.88 |
4930579D07Rik |
RIKEN cDNA 4930579D07 gene |
15177 |
0.19 |
chr4_117373339_117374157 | 31.88 |
Rnf220 |
ring finger protein 220 |
1709 |
0.34 |
chr1_155233440_155234889 | 31.79 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr15_66239660_66240017 | 31.70 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46213 |
0.14 |
chr5_65106807_65107827 | 31.65 |
Klhl5 |
kelch-like 5 |
222 |
0.92 |
chr4_101068780_101069771 | 31.63 |
Raver2 |
ribonucleoprotein, PTB-binding 2 |
204 |
0.93 |
chr2_28446566_28447382 | 31.63 |
Ppp1r26 |
protein phosphatase 1, regulatory subunit 26 |
108 |
0.95 |
chr14_6604590_6605335 | 31.56 |
Gm3629 |
predicted gene 3629 |
14349 |
0.15 |
chr4_101550249_101551121 | 31.55 |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
91 |
0.98 |
chr9_40268412_40269319 | 31.51 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr5_150593023_150594879 | 31.50 |
N4bp2l1 |
NEDD4 binding protein 2-like 1 |
182 |
0.88 |
chr7_63444022_63445137 | 31.39 |
4930554H23Rik |
RIKEN cDNA 4930554H23 gene |
50 |
0.67 |
chr18_35964956_35965372 | 31.36 |
Psd2 |
pleckstrin and Sec7 domain containing 2 |
59 |
0.96 |
chr6_72519423_72520074 | 31.34 |
Sh2d6 |
SH2 domain containing 6 |
267 |
0.88 |
chr6_124915577_124916697 | 31.29 |
Ptms |
parathymosin |
608 |
0.37 |
chr8_84414228_84414947 | 31.25 |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
777 |
0.63 |
chr2_109677143_109677796 | 31.20 |
Bdnf |
brain derived neurotrophic factor |
437 |
0.68 |
chr7_16175278_16175870 | 31.17 |
Meis3 |
Meis homeobox 3 |
144 |
0.93 |
chr16_42575508_42575977 | 31.10 |
Gm49739 |
predicted gene, 49739 |
88184 |
0.1 |
chr14_118812628_118813057 | 31.10 |
n-R5s51 |
nuclear encoded rRNA 5S 51 |
14189 |
0.15 |
chr14_4498574_4499972 | 31.01 |
Gm3173 |
predicted gene 3173 |
15485 |
0.11 |
chr14_55114673_55115704 | 30.98 |
Jph4 |
junctophilin 4 |
364 |
0.73 |
chr2_32741230_32742294 | 30.94 |
Sh2d3c |
SH2 domain containing 3C |
270 |
0.7 |
chr8_33992574_33993302 | 30.87 |
Gm45817 |
predicted gene 45817 |
5738 |
0.17 |
chr17_66448520_66450314 | 30.79 |
Mtcl1 |
microtubule crosslinking factor 1 |
333 |
0.57 |
chr5_142701305_142702538 | 30.76 |
Slc29a4 |
solute carrier family 29 (nucleoside transporters), member 4 |
180 |
0.95 |
chr18_25678986_25679896 | 30.72 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
34329 |
0.19 |
chr14_7567758_7569131 | 30.69 |
Gm3558 |
predicted gene 3558 |
122 |
0.95 |
chr8_4212633_4214018 | 30.69 |
Prr36 |
proline rich 36 |
3587 |
0.11 |
chr9_91365711_91366045 | 30.67 |
Zic1 |
zinc finger protein of the cerebellum 1 |
68 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
42.2 | 126.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
33.3 | 399.3 | GO:0071625 | vocalization behavior(GO:0071625) |
32.6 | 97.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
32.5 | 97.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
30.0 | 89.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
29.5 | 88.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
29.3 | 117.4 | GO:0030035 | microspike assembly(GO:0030035) |
29.3 | 29.3 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
28.4 | 170.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
27.7 | 83.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
27.7 | 83.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
26.8 | 80.4 | GO:0060594 | mammary gland specification(GO:0060594) |
26.0 | 26.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
25.8 | 51.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
25.8 | 154.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
25.7 | 102.9 | GO:0007412 | axon target recognition(GO:0007412) |
25.1 | 50.2 | GO:0070384 | Harderian gland development(GO:0070384) |
25.1 | 75.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
24.4 | 146.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
24.0 | 24.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
23.8 | 47.5 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
23.5 | 117.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
23.2 | 69.7 | GO:0061642 | chemoattraction of axon(GO:0061642) |
23.0 | 69.1 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
22.8 | 91.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
21.4 | 64.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
20.9 | 41.7 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
20.7 | 62.1 | GO:0021564 | vagus nerve development(GO:0021564) |
20.6 | 61.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
20.4 | 61.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
20.3 | 101.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
20.2 | 141.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
19.6 | 78.3 | GO:0061743 | motor learning(GO:0061743) |
19.3 | 96.3 | GO:0035989 | tendon development(GO:0035989) |
19.0 | 37.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
19.0 | 75.8 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
18.6 | 93.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
18.6 | 93.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
18.6 | 167.0 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
18.4 | 73.7 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
18.4 | 73.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
18.3 | 146.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
18.2 | 91.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
18.2 | 54.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
18.1 | 18.1 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
17.9 | 35.9 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
17.8 | 17.8 | GO:0021586 | pons maturation(GO:0021586) |
17.5 | 105.1 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
17.5 | 87.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
17.5 | 52.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
17.4 | 34.8 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
17.3 | 86.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
17.3 | 69.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
17.1 | 68.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
17.0 | 34.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
17.0 | 34.0 | GO:0060166 | olfactory pit development(GO:0060166) |
16.8 | 67.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
16.5 | 49.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
16.3 | 97.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
16.0 | 16.0 | GO:0021550 | medulla oblongata development(GO:0021550) |
15.9 | 270.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
15.9 | 47.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
15.8 | 31.7 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
15.6 | 62.4 | GO:0046958 | nonassociative learning(GO:0046958) |
15.6 | 31.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
15.2 | 15.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
15.2 | 121.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
15.2 | 45.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
15.1 | 45.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
15.0 | 30.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
15.0 | 44.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
14.8 | 44.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
14.8 | 44.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
14.7 | 58.7 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
14.6 | 43.9 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
14.6 | 58.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
14.5 | 14.5 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
14.5 | 43.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
14.5 | 188.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
14.3 | 28.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
14.3 | 43.0 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
14.1 | 28.3 | GO:0021603 | cranial nerve formation(GO:0021603) |
14.1 | 28.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
13.9 | 41.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
13.9 | 13.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
13.9 | 69.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
13.7 | 13.7 | GO:1903421 | positive regulation of synaptic vesicle transport(GO:1902805) regulation of synaptic vesicle recycling(GO:1903421) positive regulation of synaptic vesicle recycling(GO:1903423) |
13.6 | 54.5 | GO:0001927 | exocyst assembly(GO:0001927) |
13.6 | 40.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
13.3 | 66.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
13.2 | 158.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
13.2 | 13.2 | GO:0010970 | establishment of localization by movement along microtubule(GO:0010970) |
13.1 | 13.1 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
13.1 | 39.2 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
13.0 | 51.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
12.9 | 25.9 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
12.9 | 38.7 | GO:0097503 | sialylation(GO:0097503) |
12.9 | 77.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
12.8 | 12.8 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
12.8 | 51.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
12.8 | 38.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
12.7 | 38.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
12.7 | 25.4 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
12.7 | 12.7 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
12.6 | 265.1 | GO:0001964 | startle response(GO:0001964) |
12.6 | 50.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
12.6 | 37.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
12.6 | 37.8 | GO:0033058 | directional locomotion(GO:0033058) |
12.6 | 25.2 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
12.6 | 62.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
12.5 | 25.0 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
12.5 | 698.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
12.4 | 24.8 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
12.4 | 12.4 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
12.4 | 136.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
12.2 | 36.5 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
12.1 | 24.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
12.1 | 24.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
12.0 | 12.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
12.0 | 12.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
11.9 | 35.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
11.9 | 166.5 | GO:0008038 | neuron recognition(GO:0008038) |
11.9 | 47.5 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
11.8 | 47.4 | GO:0090427 | activation of meiosis(GO:0090427) |
11.8 | 23.6 | GO:0048664 | neuron fate determination(GO:0048664) |
11.7 | 82.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
11.7 | 70.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
11.7 | 11.7 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
11.6 | 34.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
11.5 | 23.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
11.5 | 34.5 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
11.5 | 11.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
11.5 | 22.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
11.3 | 11.3 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
11.2 | 22.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
11.1 | 11.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
11.1 | 44.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
11.0 | 22.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
11.0 | 11.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
11.0 | 43.9 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
11.0 | 43.8 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
10.9 | 43.7 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
10.8 | 43.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
10.8 | 21.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
10.8 | 86.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
10.7 | 32.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
10.6 | 74.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
10.5 | 52.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
10.4 | 31.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
10.3 | 20.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
10.3 | 20.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
10.3 | 20.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
10.3 | 20.6 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
10.3 | 30.8 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
10.3 | 41.1 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
10.3 | 30.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
10.2 | 10.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
10.2 | 10.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
10.2 | 10.2 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
10.1 | 20.2 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
10.1 | 30.2 | GO:0021764 | amygdala development(GO:0021764) |
10.0 | 100.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
10.0 | 79.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
9.9 | 79.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
9.9 | 19.8 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
9.9 | 19.8 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
9.9 | 19.7 | GO:0099612 | protein localization to axon(GO:0099612) |
9.8 | 78.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
9.7 | 9.7 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
9.7 | 87.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
9.6 | 720.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
9.6 | 38.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
9.5 | 28.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
9.5 | 18.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
9.4 | 28.3 | GO:0030070 | insulin processing(GO:0030070) |
9.4 | 9.4 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
9.4 | 18.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
9.3 | 28.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
9.3 | 9.3 | GO:0045632 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
9.3 | 18.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
9.2 | 18.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
9.2 | 27.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
9.2 | 27.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
9.1 | 27.4 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
9.1 | 45.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
9.1 | 18.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
9.0 | 45.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
9.0 | 9.0 | GO:0014029 | neural crest formation(GO:0014029) |
8.9 | 53.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
8.8 | 150.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
8.8 | 26.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
8.8 | 8.8 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
8.7 | 26.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
8.6 | 8.6 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
8.6 | 8.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
8.6 | 25.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
8.5 | 25.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
8.5 | 34.0 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
8.5 | 33.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
8.4 | 41.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
8.4 | 16.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
8.3 | 66.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
8.3 | 33.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
8.3 | 33.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
8.3 | 33.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
8.3 | 115.8 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
8.2 | 131.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
8.2 | 32.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
8.2 | 106.0 | GO:0003416 | endochondral bone growth(GO:0003416) |
8.1 | 16.3 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
8.1 | 8.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
8.0 | 64.0 | GO:0060068 | vagina development(GO:0060068) |
8.0 | 8.0 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
8.0 | 15.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
7.8 | 7.8 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
7.8 | 54.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
7.8 | 15.6 | GO:0021871 | forebrain regionalization(GO:0021871) |
7.8 | 23.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
7.8 | 23.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
7.8 | 131.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
7.7 | 7.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
7.7 | 23.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
7.7 | 23.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
7.7 | 23.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
7.6 | 38.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
7.6 | 38.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
7.6 | 22.8 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
7.6 | 22.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
7.5 | 22.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
7.5 | 22.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
7.5 | 7.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
7.4 | 22.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
7.4 | 44.6 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
7.4 | 37.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
7.4 | 29.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
7.3 | 226.3 | GO:0019228 | neuronal action potential(GO:0019228) |
7.3 | 123.9 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
7.3 | 21.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
7.2 | 21.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
7.2 | 21.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
7.2 | 14.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
7.2 | 21.6 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
7.2 | 115.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
7.2 | 35.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
7.1 | 28.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
7.0 | 7.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
6.9 | 41.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
6.9 | 20.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
6.8 | 20.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
6.8 | 20.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
6.8 | 6.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
6.7 | 27.0 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
6.7 | 20.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
6.7 | 13.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
6.7 | 13.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
6.7 | 40.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
6.7 | 26.6 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
6.6 | 19.9 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
6.6 | 118.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
6.6 | 13.2 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
6.6 | 39.5 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
6.6 | 13.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
6.6 | 45.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
6.5 | 71.9 | GO:0060384 | innervation(GO:0060384) |
6.5 | 13.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
6.5 | 26.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
6.5 | 45.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
6.5 | 13.0 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
6.5 | 225.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
6.4 | 25.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
6.4 | 19.3 | GO:0060437 | lung growth(GO:0060437) |
6.4 | 12.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
6.4 | 32.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
6.4 | 25.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
6.4 | 19.2 | GO:0090135 | actin filament branching(GO:0090135) |
6.4 | 6.4 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
6.4 | 25.6 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
6.4 | 6.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
6.4 | 70.2 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
6.4 | 57.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
6.3 | 19.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
6.3 | 6.3 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
6.3 | 31.5 | GO:0060004 | reflex(GO:0060004) |
6.3 | 12.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
6.3 | 12.6 | GO:0045759 | negative regulation of action potential(GO:0045759) |
6.3 | 18.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
6.3 | 31.4 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
6.3 | 75.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
6.3 | 18.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
6.2 | 31.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
6.2 | 31.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
6.2 | 12.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
6.2 | 18.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
6.2 | 30.9 | GO:0048570 | notochord morphogenesis(GO:0048570) |
6.2 | 67.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
6.2 | 6.2 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
6.1 | 12.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
6.1 | 12.3 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
6.1 | 6.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
6.1 | 18.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
6.1 | 24.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
6.1 | 36.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
6.0 | 12.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
6.0 | 30.0 | GO:0015884 | folic acid transport(GO:0015884) |
6.0 | 6.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
6.0 | 23.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
6.0 | 35.8 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
5.9 | 5.9 | GO:1902837 | amino acid import into cell(GO:1902837) |
5.9 | 5.9 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
5.9 | 41.3 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
5.9 | 11.8 | GO:0061055 | myotome development(GO:0061055) |
5.9 | 82.3 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
5.8 | 52.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
5.8 | 11.6 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
5.8 | 5.8 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
5.8 | 5.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
5.7 | 23.0 | GO:0060179 | male mating behavior(GO:0060179) |
5.7 | 40.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
5.7 | 11.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
5.6 | 50.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
5.6 | 22.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
5.6 | 16.7 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
5.5 | 27.5 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
5.5 | 27.4 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
5.5 | 11.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
5.5 | 11.0 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
5.5 | 21.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
5.5 | 5.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
5.5 | 65.4 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
5.4 | 5.4 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
5.4 | 27.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
5.4 | 5.4 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
5.4 | 10.8 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
5.4 | 21.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
5.4 | 64.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
5.4 | 5.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
5.3 | 5.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
5.3 | 521.0 | GO:0097485 | neuron projection guidance(GO:0097485) |
5.3 | 15.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
5.3 | 21.1 | GO:0030091 | protein repair(GO:0030091) |
5.3 | 10.6 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
5.3 | 15.8 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
5.3 | 15.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
5.2 | 15.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
5.2 | 542.2 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
5.1 | 15.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
5.1 | 10.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
5.1 | 15.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
5.0 | 5.0 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
5.0 | 40.3 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
5.0 | 5.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
5.0 | 10.0 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
5.0 | 34.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
5.0 | 69.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
4.9 | 9.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
4.9 | 9.9 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
4.9 | 9.9 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
4.9 | 4.9 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
4.9 | 9.8 | GO:0008355 | olfactory learning(GO:0008355) |
4.8 | 72.3 | GO:0007416 | synapse assembly(GO:0007416) |
4.8 | 9.6 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
4.8 | 4.8 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
4.8 | 14.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
4.7 | 14.1 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
4.7 | 14.0 | GO:0014819 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of skeletal muscle contraction(GO:0014819) |
4.6 | 36.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
4.6 | 9.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
4.5 | 13.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
4.5 | 9.1 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
4.5 | 9.1 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
4.5 | 4.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
4.5 | 18.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
4.5 | 4.5 | GO:0003207 | cardiac chamber formation(GO:0003207) |
4.5 | 49.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
4.5 | 4.5 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
4.5 | 9.0 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
4.5 | 17.9 | GO:0033227 | dsRNA transport(GO:0033227) |
4.4 | 30.9 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
4.4 | 30.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
4.4 | 22.0 | GO:0021854 | hypothalamus development(GO:0021854) |
4.4 | 4.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
4.4 | 13.2 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
4.4 | 13.2 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
4.4 | 43.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
4.4 | 13.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
4.4 | 47.9 | GO:0036065 | fucosylation(GO:0036065) |
4.3 | 13.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
4.3 | 17.4 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
4.3 | 42.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
4.2 | 17.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
4.2 | 21.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
4.2 | 8.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
4.2 | 8.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
4.2 | 4.2 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
4.2 | 4.2 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
4.1 | 12.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
4.1 | 16.4 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
4.1 | 12.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
4.0 | 12.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
4.0 | 4.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
4.0 | 16.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
4.0 | 8.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
4.0 | 4.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
4.0 | 4.0 | GO:0051665 | membrane raft localization(GO:0051665) |
4.0 | 15.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
4.0 | 4.0 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
4.0 | 7.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
3.9 | 7.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
3.9 | 3.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
3.9 | 7.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
3.9 | 3.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
3.9 | 27.0 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
3.9 | 3.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
3.9 | 15.4 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) positive regulation of catenin import into nucleus(GO:0035413) |
3.8 | 3.8 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
3.8 | 3.8 | GO:0072174 | metanephric tubule formation(GO:0072174) |
3.8 | 23.0 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
3.8 | 7.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
3.8 | 15.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
3.8 | 15.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
3.8 | 30.4 | GO:0010842 | retina layer formation(GO:0010842) |
3.8 | 71.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
3.8 | 3.8 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
3.8 | 45.1 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
3.8 | 7.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
3.7 | 63.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
3.7 | 22.4 | GO:0060736 | prostate gland growth(GO:0060736) |
3.7 | 3.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
3.7 | 14.9 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
3.7 | 14.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
3.7 | 14.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
3.7 | 22.1 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
3.7 | 14.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
3.7 | 11.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
3.7 | 3.7 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
3.7 | 7.3 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
3.7 | 3.7 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
3.6 | 10.9 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
3.6 | 7.3 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
3.6 | 25.3 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
3.6 | 7.2 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
3.6 | 7.2 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
3.6 | 10.7 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
3.5 | 21.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
3.5 | 10.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
3.5 | 7.0 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
3.5 | 10.6 | GO:0043586 | tongue development(GO:0043586) |
3.5 | 14.1 | GO:0031000 | response to caffeine(GO:0031000) |
3.5 | 7.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
3.5 | 3.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
3.5 | 3.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
3.5 | 7.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
3.5 | 3.5 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
3.4 | 24.1 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
3.4 | 6.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
3.4 | 24.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
3.4 | 17.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
3.4 | 10.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
3.4 | 27.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
3.4 | 6.7 | GO:0015819 | lysine transport(GO:0015819) |
3.4 | 26.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
3.3 | 16.7 | GO:0042428 | serotonin metabolic process(GO:0042428) |
3.3 | 86.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
3.3 | 6.7 | GO:0019042 | viral latency(GO:0019042) |
3.3 | 6.7 | GO:0050955 | thermoception(GO:0050955) |
3.3 | 26.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
3.3 | 3.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
3.3 | 19.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
3.3 | 13.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
3.3 | 22.9 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
3.3 | 13.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
3.3 | 6.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
3.3 | 16.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
3.3 | 6.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
3.2 | 6.4 | GO:0001757 | somite specification(GO:0001757) |
3.2 | 6.4 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
3.2 | 41.0 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
3.2 | 22.1 | GO:0006108 | malate metabolic process(GO:0006108) |
3.2 | 6.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
3.1 | 15.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
3.1 | 9.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.1 | 15.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
3.1 | 21.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
3.1 | 12.4 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
3.1 | 18.5 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
3.1 | 3.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
3.1 | 3.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
3.0 | 18.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
3.0 | 12.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
3.0 | 3.0 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
3.0 | 6.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
3.0 | 12.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
3.0 | 6.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.0 | 35.9 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
3.0 | 14.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
3.0 | 17.9 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
3.0 | 3.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
3.0 | 32.7 | GO:0003334 | keratinocyte development(GO:0003334) |
3.0 | 3.0 | GO:2001023 | regulation of response to drug(GO:2001023) positive regulation of response to drug(GO:2001025) |
3.0 | 14.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.9 | 52.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
2.9 | 17.6 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
2.9 | 2.9 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
2.9 | 8.8 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
2.9 | 5.9 | GO:0030432 | peristalsis(GO:0030432) |
2.9 | 8.8 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
2.9 | 20.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
2.9 | 11.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
2.9 | 14.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
2.9 | 8.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
2.9 | 8.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.9 | 2.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
2.9 | 8.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
2.8 | 17.1 | GO:0030903 | notochord development(GO:0030903) |
2.8 | 2.8 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
2.8 | 2.8 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
2.8 | 11.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
2.8 | 5.7 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
2.8 | 11.3 | GO:0033762 | response to glucagon(GO:0033762) |
2.8 | 8.5 | GO:1990403 | embryonic brain development(GO:1990403) |
2.8 | 8.4 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
2.8 | 5.6 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
2.8 | 19.6 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
2.8 | 2.8 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
2.8 | 8.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.8 | 22.3 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
2.8 | 8.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
2.8 | 2.8 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
2.7 | 46.7 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
2.7 | 10.9 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
2.7 | 8.2 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
2.7 | 8.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
2.7 | 5.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
2.7 | 10.7 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
2.7 | 16.0 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
2.6 | 7.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
2.6 | 7.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
2.6 | 10.4 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
2.6 | 5.2 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
2.6 | 20.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
2.6 | 5.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
2.6 | 2.6 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
2.6 | 5.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
2.6 | 5.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
2.5 | 5.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
2.5 | 5.0 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
2.5 | 7.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
2.5 | 22.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
2.5 | 12.6 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
2.5 | 17.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
2.5 | 5.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
2.5 | 172.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
2.5 | 12.5 | GO:0016322 | neuron remodeling(GO:0016322) |
2.5 | 2.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
2.5 | 5.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.5 | 7.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
2.5 | 4.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
2.5 | 4.9 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
2.4 | 4.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
2.4 | 4.9 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
2.4 | 7.3 | GO:0032252 | secretory granule localization(GO:0032252) |
2.4 | 17.0 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
2.4 | 2.4 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
2.4 | 2.4 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
2.4 | 7.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
2.4 | 2.4 | GO:0061548 | ganglion development(GO:0061548) |
2.4 | 2.4 | GO:0072053 | renal inner medulla development(GO:0072053) |
2.4 | 16.7 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
2.4 | 4.8 | GO:0031296 | B cell costimulation(GO:0031296) |
2.4 | 2.4 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
2.4 | 9.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
2.4 | 16.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
2.3 | 32.9 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
2.3 | 18.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
2.3 | 9.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
2.3 | 2.3 | GO:0034331 | cell junction maintenance(GO:0034331) |
2.3 | 4.7 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
2.3 | 16.3 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
2.3 | 27.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
2.3 | 44.1 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
2.3 | 4.6 | GO:0070459 | prolactin secretion(GO:0070459) |
2.3 | 6.9 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
2.3 | 11.5 | GO:0051451 | myoblast migration(GO:0051451) |
2.3 | 16.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
2.3 | 2.3 | GO:2000407 | T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
2.3 | 6.8 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
2.3 | 4.5 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
2.2 | 4.5 | GO:0003032 | detection of oxygen(GO:0003032) |
2.2 | 62.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
2.2 | 19.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
2.2 | 6.6 | GO:0060033 | anatomical structure regression(GO:0060033) |
2.2 | 15.4 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
2.2 | 6.6 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
2.2 | 19.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
2.2 | 17.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
2.2 | 6.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
2.2 | 6.6 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
2.2 | 4.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
2.2 | 30.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
2.2 | 2.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
2.2 | 2.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
2.2 | 2.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
2.2 | 4.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
2.2 | 2.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
2.1 | 17.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
2.1 | 12.9 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
2.1 | 6.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
2.1 | 17.0 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
2.1 | 6.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
2.1 | 4.2 | GO:0006868 | glutamine transport(GO:0006868) |
2.1 | 2.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
2.1 | 4.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
2.1 | 2.1 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
2.1 | 2.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
2.1 | 6.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.1 | 24.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
2.1 | 6.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.1 | 4.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
2.0 | 4.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
2.0 | 26.4 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
2.0 | 2.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
2.0 | 6.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
2.0 | 16.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
2.0 | 24.1 | GO:0008347 | glial cell migration(GO:0008347) |
2.0 | 2.0 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
2.0 | 6.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
2.0 | 2.0 | GO:0017085 | response to insecticide(GO:0017085) |
2.0 | 4.0 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
2.0 | 5.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
2.0 | 7.9 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
2.0 | 25.5 | GO:0015844 | monoamine transport(GO:0015844) |
2.0 | 2.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.9 | 3.9 | GO:0046655 | folic acid metabolic process(GO:0046655) |
1.9 | 9.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.9 | 3.9 | GO:0051182 | coenzyme transport(GO:0051182) |
1.9 | 1.9 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
1.9 | 9.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
1.9 | 7.6 | GO:0018158 | protein oxidation(GO:0018158) |
1.9 | 18.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
1.9 | 11.2 | GO:0051450 | myoblast proliferation(GO:0051450) |
1.9 | 39.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
1.9 | 5.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.8 | 9.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.8 | 10.9 | GO:0042772 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
1.8 | 5.4 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.8 | 10.9 | GO:0015074 | DNA integration(GO:0015074) |
1.8 | 1.8 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
1.8 | 9.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
1.8 | 5.4 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.8 | 7.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
1.8 | 3.6 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.8 | 3.6 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
1.8 | 3.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.8 | 98.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
1.8 | 10.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.7 | 10.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.7 | 69.2 | GO:0001764 | neuron migration(GO:0001764) |
1.7 | 3.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.7 | 38.0 | GO:0034605 | cellular response to heat(GO:0034605) |
1.7 | 1.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.7 | 1.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.7 | 6.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.7 | 5.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.7 | 8.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.7 | 28.9 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
1.7 | 5.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.7 | 1.7 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.7 | 1.7 | GO:2000855 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
1.7 | 18.6 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
1.7 | 3.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.7 | 1.7 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
1.7 | 6.7 | GO:0007614 | short-term memory(GO:0007614) |
1.7 | 1.7 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
1.7 | 1.7 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
1.7 | 1.7 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
1.6 | 1.6 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.6 | 4.9 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
1.6 | 1.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.6 | 1.6 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.6 | 6.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.6 | 4.8 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
1.6 | 4.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.6 | 6.4 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
1.6 | 12.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.6 | 12.7 | GO:0030575 | nuclear body organization(GO:0030575) |
1.6 | 3.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.6 | 7.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
1.6 | 3.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.6 | 4.7 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.6 | 3.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
1.6 | 6.3 | GO:0022029 | telencephalon cell migration(GO:0022029) |
1.6 | 6.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.6 | 4.7 | GO:0032835 | glomerulus development(GO:0032835) |
1.5 | 4.6 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
1.5 | 4.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
1.5 | 23.1 | GO:0006491 | N-glycan processing(GO:0006491) |
1.5 | 1.5 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
1.5 | 4.6 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
1.5 | 6.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
1.5 | 6.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.5 | 37.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.5 | 1.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.5 | 3.0 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.5 | 4.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.5 | 52.6 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
1.5 | 3.0 | GO:0090383 | phagosome acidification(GO:0090383) |
1.5 | 1.5 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
1.5 | 3.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.5 | 1.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.5 | 1.5 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
1.5 | 2.9 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
1.5 | 1.5 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
1.5 | 10.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
1.5 | 1.5 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
1.5 | 4.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
1.4 | 2.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.4 | 1.4 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
1.4 | 1.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.4 | 10.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
1.4 | 1.4 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
1.4 | 7.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.4 | 1.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.4 | 4.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
1.4 | 7.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.4 | 1.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
1.4 | 2.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.4 | 9.8 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
1.4 | 29.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.4 | 23.8 | GO:0007340 | acrosome reaction(GO:0007340) |
1.4 | 21.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
1.4 | 25.1 | GO:0009268 | response to pH(GO:0009268) |
1.4 | 1.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.4 | 2.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
1.4 | 5.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.4 | 6.9 | GO:0060347 | heart trabecula formation(GO:0060347) |
1.4 | 12.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
1.4 | 4.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
1.3 | 5.4 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
1.3 | 5.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.3 | 4.0 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
1.3 | 2.6 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
1.3 | 1.3 | GO:0015705 | iodide transport(GO:0015705) |
1.3 | 1.3 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
1.3 | 2.6 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.3 | 3.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.3 | 2.6 | GO:0021554 | optic nerve development(GO:0021554) |
1.3 | 1.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
1.3 | 2.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
1.3 | 2.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
1.3 | 15.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.3 | 2.5 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.2 | 19.9 | GO:0008542 | visual learning(GO:0008542) |
1.2 | 1.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.2 | 2.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.2 | 3.7 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.2 | 8.5 | GO:0021987 | cerebral cortex development(GO:0021987) |
1.2 | 3.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.2 | 12.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
1.2 | 1.2 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
1.2 | 4.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.2 | 5.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.2 | 5.9 | GO:0009624 | response to nematode(GO:0009624) |
1.2 | 5.9 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.2 | 1.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
1.1 | 2.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.1 | 1.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
1.1 | 1.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
1.1 | 2.3 | GO:0051013 | microtubule severing(GO:0051013) |
1.1 | 15.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.1 | 1.1 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
1.1 | 10.1 | GO:0007135 | meiosis II(GO:0007135) |
1.1 | 7.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
1.1 | 3.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.1 | 2.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.1 | 14.2 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
1.1 | 2.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.1 | 4.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
1.1 | 19.3 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
1.1 | 2.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
1.1 | 8.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
1.1 | 3.2 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
1.1 | 4.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
1.1 | 12.6 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
1.1 | 3.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.1 | 3.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
1.0 | 2.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.0 | 7.3 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
1.0 | 5.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
1.0 | 1.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
1.0 | 3.1 | GO:0042891 | antibiotic transport(GO:0042891) |
1.0 | 10.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
1.0 | 5.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.0 | 2.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
1.0 | 3.0 | GO:0061337 | cardiac conduction(GO:0061337) |
1.0 | 9.0 | GO:0033622 | integrin activation(GO:0033622) |
1.0 | 1.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.0 | 3.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.0 | 5.9 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
1.0 | 9.8 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
1.0 | 2.9 | GO:0015747 | urate transport(GO:0015747) |
1.0 | 9.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
1.0 | 2.9 | GO:0002836 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
1.0 | 11.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
1.0 | 6.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.9 | 9.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.9 | 5.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.9 | 1.9 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.9 | 4.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.9 | 1.9 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.9 | 0.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.9 | 1.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.9 | 5.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.9 | 0.9 | GO:0008354 | germ cell migration(GO:0008354) |
0.9 | 3.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.9 | 1.8 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.9 | 0.9 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.9 | 8.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.9 | 0.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.9 | 2.6 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.9 | 3.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.9 | 3.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.9 | 10.5 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.9 | 3.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.9 | 1.7 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.9 | 1.7 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.9 | 4.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.8 | 0.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.8 | 4.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.8 | 1.7 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) |
0.8 | 2.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.8 | 5.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.8 | 3.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.8 | 0.8 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.8 | 1.7 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.8 | 3.3 | GO:0006983 | ER overload response(GO:0006983) |
0.8 | 2.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.8 | 4.8 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.8 | 0.8 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.8 | 0.8 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.8 | 11.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.8 | 0.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.8 | 1.6 | GO:1903726 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of phospholipid metabolic process(GO:1903726) |
0.8 | 2.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.8 | 1.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.8 | 2.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.8 | 2.3 | GO:0046618 | drug export(GO:0046618) |
0.7 | 2.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.7 | 2.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.7 | 3.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.7 | 1.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.7 | 0.7 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.7 | 18.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.7 | 4.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.7 | 2.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.7 | 0.7 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.7 | 0.7 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.7 | 1.4 | GO:0032570 | response to progesterone(GO:0032570) |
0.7 | 4.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.7 | 3.5 | GO:0015858 | nucleoside transport(GO:0015858) |
0.7 | 2.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.7 | 0.7 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.7 | 15.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.7 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.7 | 2.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.7 | 4.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.6 | 0.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.6 | 1.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.6 | 1.9 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.6 | 1.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.6 | 1.9 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.6 | 1.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.6 | 0.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.6 | 4.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.6 | 0.6 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.6 | 0.6 | GO:0060618 | nipple development(GO:0060618) |
0.6 | 0.6 | GO:0002339 | B cell selection(GO:0002339) |
0.6 | 6.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.6 | 0.6 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.6 | 1.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.6 | 0.6 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.6 | 4.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.5 | 1.6 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.5 | 1.6 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.5 | 0.5 | GO:0021544 | subpallium development(GO:0021544) |
0.5 | 1.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.5 | 0.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.5 | 1.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.5 | 1.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.5 | 3.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.5 | 0.5 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.5 | 1.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.5 | 0.5 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.5 | 0.5 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.5 | 5.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.5 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
0.5 | 0.5 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 1.8 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 0.4 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.4 | 0.9 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.4 | 2.6 | GO:0014002 | astrocyte development(GO:0014002) |
0.4 | 0.9 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.4 | 0.9 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.4 | 0.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.4 | 4.3 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.4 | 0.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.4 | 7.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.4 | 2.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.4 | 2.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 1.6 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.4 | 2.8 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.4 | 7.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.4 | 6.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.4 | 1.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 1.1 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.4 | 0.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 0.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 0.4 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 0.7 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 0.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.3 | 1.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.3 | 9.4 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 0.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 0.7 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 0.3 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.3 | 0.7 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 0.6 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.3 | 0.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.3 | 0.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 2.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.3 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 0.3 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.3 | 1.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 0.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 0.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 0.8 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.3 | 0.6 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 11.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 0.3 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.3 | 1.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 0.5 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 0.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 1.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.3 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.3 | 0.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 1.5 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 1.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 0.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 1.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 4.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.5 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 1.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 1.6 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 0.4 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.2 | 0.9 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.2 | 0.4 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.2 | 0.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 3.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.2 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.2 | 0.8 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 2.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 1.4 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.2 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.2 | 1.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 6.4 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.2 | 1.9 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.2 | 0.2 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.2 | 0.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 5.2 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.2 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 6.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.2 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.4 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 1.0 | GO:0001508 | action potential(GO:0001508) |
0.1 | 4.6 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.3 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.8 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 1.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 1.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.1 | GO:0002858 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 5.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.6 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.9 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.0 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.3 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
37.3 | 111.8 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
33.9 | 33.9 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
23.7 | 118.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
22.8 | 91.2 | GO:0044308 | axonal spine(GO:0044308) |
22.3 | 155.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
21.1 | 126.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
20.4 | 61.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
19.4 | 77.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
17.8 | 142.5 | GO:0043083 | synaptic cleft(GO:0043083) |
17.7 | 159.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
17.6 | 492.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
16.4 | 131.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
15.7 | 47.1 | GO:0043511 | inhibin complex(GO:0043511) |
15.7 | 47.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
15.6 | 46.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
14.9 | 14.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
14.7 | 147.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
14.5 | 159.8 | GO:0043194 | axon initial segment(GO:0043194) |
14.4 | 201.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
14.4 | 201.2 | GO:0030673 | axolemma(GO:0030673) |
14.0 | 14.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
13.8 | 358.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
13.2 | 408.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
13.0 | 13.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
12.8 | 153.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
12.7 | 12.7 | GO:0005883 | neurofilament(GO:0005883) |
12.6 | 37.7 | GO:0072534 | perineuronal net(GO:0072534) |
11.1 | 100.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
10.7 | 107.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
10.7 | 32.2 | GO:0097427 | microtubule bundle(GO:0097427) |
10.7 | 149.9 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
10.6 | 10.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
10.3 | 256.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
10.1 | 30.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
10.0 | 50.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
9.8 | 48.9 | GO:0043219 | lateral loop(GO:0043219) |
9.7 | 58.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
9.7 | 29.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
9.4 | 102.9 | GO:0031527 | filopodium membrane(GO:0031527) |
9.2 | 27.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
8.8 | 8.8 | GO:0097386 | glial cell projection(GO:0097386) |
8.7 | 26.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
8.4 | 481.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
8.0 | 47.9 | GO:0005915 | zonula adherens(GO:0005915) |
7.8 | 15.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
7.7 | 38.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
7.7 | 46.0 | GO:0032584 | growth cone membrane(GO:0032584) |
7.6 | 22.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
7.6 | 7.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
7.4 | 51.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
7.3 | 80.7 | GO:0001527 | microfibril(GO:0001527) |
7.3 | 21.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
6.9 | 917.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
6.9 | 82.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
6.7 | 200.6 | GO:0043198 | dendritic shaft(GO:0043198) |
6.2 | 37.3 | GO:0097440 | apical dendrite(GO:0097440) |
6.1 | 36.8 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
6.1 | 96.8 | GO:0044298 | cell body membrane(GO:0044298) |
5.9 | 11.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
5.8 | 17.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
5.5 | 54.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
5.5 | 21.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
5.4 | 5.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
5.4 | 64.9 | GO:0031045 | dense core granule(GO:0031045) |
5.4 | 16.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
5.3 | 10.6 | GO:0097441 | basilar dendrite(GO:0097441) |
5.3 | 26.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
5.1 | 10.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
5.1 | 5.1 | GO:0097513 | myosin II filament(GO:0097513) |
5.1 | 15.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
5.1 | 46.0 | GO:0097542 | ciliary tip(GO:0097542) |
5.0 | 144.9 | GO:0031941 | filamentous actin(GO:0031941) |
5.0 | 10.0 | GO:0000235 | astral microtubule(GO:0000235) |
5.0 | 19.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
4.8 | 658.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
4.7 | 18.9 | GO:0044327 | dendritic spine head(GO:0044327) |
4.7 | 4.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
4.7 | 9.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
4.7 | 4.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
4.6 | 23.2 | GO:0016589 | NURF complex(GO:0016589) |
4.6 | 69.3 | GO:0005614 | interstitial matrix(GO:0005614) |
4.5 | 9.1 | GO:0016342 | catenin complex(GO:0016342) |
4.5 | 4.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
4.5 | 58.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
4.4 | 194.5 | GO:0030175 | filopodium(GO:0030175) |
4.4 | 13.2 | GO:0033010 | paranodal junction(GO:0033010) |
4.3 | 4.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
4.3 | 419.7 | GO:0060076 | excitatory synapse(GO:0060076) |
4.3 | 17.2 | GO:0097433 | dense body(GO:0097433) |
4.2 | 12.7 | GO:0071953 | elastic fiber(GO:0071953) |
4.2 | 37.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
4.2 | 16.7 | GO:0071203 | WASH complex(GO:0071203) |
4.0 | 128.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
4.0 | 114.8 | GO:0005921 | gap junction(GO:0005921) |
3.9 | 23.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
3.8 | 23.0 | GO:0001652 | granular component(GO:0001652) |
3.7 | 7.5 | GO:0043256 | laminin complex(GO:0043256) |
3.7 | 14.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
3.6 | 43.1 | GO:0044295 | axonal growth cone(GO:0044295) |
3.6 | 17.9 | GO:0097449 | astrocyte projection(GO:0097449) |
3.5 | 31.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
3.4 | 210.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
3.4 | 13.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
3.3 | 1004.6 | GO:0045202 | synapse(GO:0045202) |
3.2 | 28.8 | GO:0036156 | inner dynein arm(GO:0036156) |
3.1 | 12.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
3.1 | 6.2 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
3.1 | 40.0 | GO:0034704 | calcium channel complex(GO:0034704) |
3.1 | 735.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
3.0 | 14.9 | GO:0032590 | dendrite membrane(GO:0032590) |
2.9 | 2.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
2.9 | 17.1 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
2.8 | 14.2 | GO:0071547 | piP-body(GO:0071547) |
2.8 | 25.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
2.8 | 83.5 | GO:0005581 | collagen trimer(GO:0005581) |
2.6 | 18.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
2.6 | 13.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
2.6 | 7.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
2.6 | 41.7 | GO:0030904 | retromer complex(GO:0030904) |
2.6 | 20.6 | GO:0005861 | troponin complex(GO:0005861) |
2.5 | 15.1 | GO:0030315 | T-tubule(GO:0030315) |
2.5 | 10.0 | GO:0070545 | PeBoW complex(GO:0070545) |
2.4 | 9.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
2.3 | 6.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
2.3 | 6.9 | GO:0042583 | chromaffin granule(GO:0042583) |
2.3 | 18.2 | GO:0036157 | outer dynein arm(GO:0036157) |
2.3 | 6.8 | GO:1990393 | 3M complex(GO:1990393) |
2.2 | 8.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
2.2 | 17.2 | GO:0001520 | outer dense fiber(GO:0001520) |
2.1 | 29.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
2.1 | 22.8 | GO:0035102 | PRC1 complex(GO:0035102) |
2.0 | 16.4 | GO:0031143 | pseudopodium(GO:0031143) |
2.0 | 2.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
2.0 | 14.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
2.0 | 22.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
2.0 | 11.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.9 | 1.9 | GO:0070820 | tertiary granule(GO:0070820) |
1.8 | 94.1 | GO:0043204 | perikaryon(GO:0043204) |
1.8 | 78.4 | GO:0005901 | caveola(GO:0005901) |
1.7 | 3.5 | GO:0033503 | HULC complex(GO:0033503) |
1.7 | 5.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.7 | 6.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.7 | 1.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.7 | 20.6 | GO:0046930 | pore complex(GO:0046930) |
1.7 | 5.1 | GO:0048179 | activin receptor complex(GO:0048179) |
1.7 | 3.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.7 | 127.0 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
1.7 | 23.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.7 | 8.3 | GO:0042629 | mast cell granule(GO:0042629) |
1.6 | 6.3 | GO:0071546 | pi-body(GO:0071546) |
1.5 | 1.5 | GO:0044393 | microspike(GO:0044393) |
1.5 | 10.6 | GO:0097546 | ciliary base(GO:0097546) |
1.5 | 8.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.5 | 20.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
1.5 | 8.8 | GO:0044292 | dendrite terminus(GO:0044292) |
1.5 | 5.8 | GO:0045180 | basal cortex(GO:0045180) |
1.5 | 14.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.5 | 5.8 | GO:0031209 | SCAR complex(GO:0031209) |
1.4 | 10.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
1.4 | 5.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.4 | 15.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.4 | 1.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.4 | 4.1 | GO:0030478 | actin cap(GO:0030478) |
1.3 | 112.8 | GO:0030424 | axon(GO:0030424) |
1.3 | 10.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.3 | 3.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.3 | 23.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.2 | 39.1 | GO:0030426 | growth cone(GO:0030426) |
1.2 | 1.2 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
1.2 | 26.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.2 | 4.8 | GO:0097452 | GAIT complex(GO:0097452) |
1.2 | 1.2 | GO:0032437 | cuticular plate(GO:0032437) |
1.2 | 4.6 | GO:0071817 | MMXD complex(GO:0071817) |
1.1 | 3.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.1 | 7.9 | GO:0031253 | cell projection membrane(GO:0031253) |
1.1 | 61.0 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
1.1 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.1 | 48.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.1 | 6.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.1 | 4.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
1.1 | 2.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
1.0 | 14.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.0 | 7.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.0 | 10.8 | GO:0032420 | stereocilium(GO:0032420) |
0.9 | 125.3 | GO:0030425 | dendrite(GO:0030425) |
0.9 | 33.8 | GO:0005871 | kinesin complex(GO:0005871) |
0.9 | 0.9 | GO:0034705 | potassium channel complex(GO:0034705) |
0.9 | 10.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.9 | 12.9 | GO:0001741 | XY body(GO:0001741) |
0.9 | 21.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.9 | 3.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.9 | 2.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.9 | 8.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.9 | 2.7 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.9 | 6.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.9 | 7.0 | GO:0030057 | desmosome(GO:0030057) |
0.9 | 5.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.8 | 2.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.8 | 40.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.8 | 4.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.8 | 4.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.8 | 6.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.7 | 7.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.7 | 3.6 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 22.4 | GO:0005884 | actin filament(GO:0005884) |
0.7 | 5.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.7 | 2.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.7 | 12.2 | GO:0016235 | aggresome(GO:0016235) |
0.6 | 2.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.6 | 3.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 513.2 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.6 | 41.8 | GO:0043025 | neuronal cell body(GO:0043025) |
0.6 | 1.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.6 | 0.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.6 | 19.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.6 | 2116.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.5 | 1.1 | GO:0000802 | transverse filament(GO:0000802) |
0.5 | 1.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 1.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 27.6 | GO:0043005 | neuron projection(GO:0043005) |
0.5 | 1.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.5 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.5 | 0.5 | GO:0070069 | cytochrome complex(GO:0070069) |
0.4 | 3.0 | GO:0031902 | late endosome membrane(GO:0031902) |
0.4 | 5.9 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.4 | 6.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.4 | 3.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.4 | 1.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.4 | 1.5 | GO:0032021 | NELF complex(GO:0032021) |
0.4 | 1.2 | GO:0036396 | MIS complex(GO:0036396) |
0.4 | 4.1 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 4.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.3 | 17.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.3 | 1.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 1.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 1.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 25.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 0.6 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 2.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 4.1 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 5.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 1.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.4 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 1.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
37.5 | 112.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
36.4 | 109.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
31.5 | 94.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
31.3 | 156.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
28.0 | 84.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
28.0 | 83.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
26.4 | 105.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
26.1 | 156.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
24.3 | 48.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
24.1 | 72.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
21.5 | 21.5 | GO:0038191 | neuropilin binding(GO:0038191) |
20.3 | 101.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
20.3 | 40.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
19.7 | 59.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
19.0 | 75.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
18.9 | 94.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
18.9 | 56.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
18.8 | 75.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
18.4 | 55.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
18.4 | 73.4 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
18.2 | 72.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
18.0 | 89.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
17.9 | 53.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
17.7 | 17.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
17.1 | 255.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
16.2 | 113.7 | GO:0003680 | AT DNA binding(GO:0003680) |
16.2 | 80.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
16.1 | 129.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
15.7 | 62.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
15.6 | 46.9 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
15.6 | 46.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
15.1 | 45.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
14.2 | 28.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
14.2 | 42.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
14.1 | 42.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
14.0 | 251.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
13.8 | 55.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
13.8 | 69.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
13.8 | 124.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
13.4 | 107.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
13.3 | 66.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
12.8 | 51.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
12.7 | 50.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
12.6 | 50.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
12.5 | 49.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
11.7 | 11.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
11.7 | 70.1 | GO:0048495 | Roundabout binding(GO:0048495) |
11.7 | 11.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
11.5 | 46.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
11.4 | 22.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
11.3 | 45.2 | GO:0070052 | collagen V binding(GO:0070052) |
11.1 | 22.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
10.8 | 140.7 | GO:0031005 | filamin binding(GO:0031005) |
10.7 | 42.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
10.5 | 73.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
10.4 | 269.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
10.3 | 308.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
10.0 | 80.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
9.9 | 257.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
9.7 | 19.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
9.7 | 106.9 | GO:0005522 | profilin binding(GO:0005522) |
9.6 | 19.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
9.5 | 37.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
9.2 | 36.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
9.1 | 353.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
9.0 | 9.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
9.0 | 27.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
9.0 | 26.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
8.9 | 62.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
8.8 | 8.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
8.8 | 44.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
8.7 | 26.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
8.6 | 25.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
8.6 | 68.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
8.6 | 43.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
8.5 | 34.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
8.4 | 58.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
8.3 | 50.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
8.3 | 41.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
8.3 | 24.9 | GO:0051373 | FATZ binding(GO:0051373) |
8.3 | 33.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
8.1 | 40.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
8.1 | 8.1 | GO:0045340 | mercury ion binding(GO:0045340) |
8.0 | 16.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
8.0 | 31.9 | GO:0071253 | connexin binding(GO:0071253) |
7.9 | 103.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
7.9 | 23.6 | GO:0035939 | microsatellite binding(GO:0035939) |
7.9 | 15.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
7.7 | 23.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
7.7 | 15.4 | GO:0097016 | L27 domain binding(GO:0097016) |
7.7 | 23.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
7.5 | 37.7 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
7.5 | 37.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
7.4 | 22.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
7.4 | 22.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
7.3 | 73.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
7.3 | 36.7 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
7.3 | 58.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
7.2 | 72.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
7.2 | 93.1 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
7.2 | 143.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
7.1 | 35.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
7.1 | 49.4 | GO:0034711 | inhibin binding(GO:0034711) |
7.0 | 224.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
7.0 | 49.0 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
6.9 | 20.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
6.7 | 13.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
6.6 | 19.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
6.6 | 131.5 | GO:0003785 | actin monomer binding(GO:0003785) |
6.5 | 65.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
6.5 | 26.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
6.5 | 19.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
6.5 | 25.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
6.4 | 122.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
6.4 | 6.4 | GO:0031014 | troponin T binding(GO:0031014) |
6.4 | 25.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
6.4 | 139.9 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
6.4 | 6.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
6.3 | 12.6 | GO:0070905 | serine binding(GO:0070905) |
6.3 | 18.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
6.2 | 37.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
6.2 | 179.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
6.2 | 24.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
6.1 | 30.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
6.1 | 30.7 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
6.0 | 217.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
6.0 | 48.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
6.0 | 11.9 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
6.0 | 47.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
5.9 | 35.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
5.9 | 11.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
5.9 | 17.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
5.9 | 17.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
5.9 | 17.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
5.9 | 329.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
5.7 | 113.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
5.7 | 39.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
5.7 | 17.0 | GO:0048185 | activin binding(GO:0048185) |
5.6 | 16.9 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
5.6 | 16.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
5.4 | 59.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
5.4 | 27.2 | GO:1990254 | keratin filament binding(GO:1990254) |
5.4 | 5.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
5.2 | 15.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
5.2 | 15.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
5.2 | 15.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
5.1 | 25.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
5.1 | 20.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
5.1 | 50.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
5.0 | 30.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
5.0 | 5.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
5.0 | 24.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
5.0 | 59.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
4.9 | 14.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
4.9 | 24.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
4.9 | 24.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
4.9 | 53.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
4.8 | 101.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
4.8 | 28.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
4.7 | 14.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
4.7 | 4.7 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
4.7 | 9.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
4.7 | 18.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
4.6 | 18.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
4.5 | 40.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
4.5 | 4.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
4.5 | 17.9 | GO:0030506 | ankyrin binding(GO:0030506) |
4.5 | 62.6 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
4.4 | 26.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
4.4 | 105.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
4.4 | 35.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
4.3 | 30.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
4.3 | 34.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
4.3 | 17.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
4.3 | 12.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
4.3 | 38.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
4.3 | 21.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
4.3 | 25.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
4.3 | 38.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
4.2 | 72.0 | GO:0005112 | Notch binding(GO:0005112) |
4.2 | 41.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
4.1 | 12.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
4.1 | 152.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
4.1 | 12.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
4.1 | 41.0 | GO:0030955 | potassium ion binding(GO:0030955) |
4.1 | 36.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
4.1 | 36.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
4.1 | 8.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
4.1 | 12.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
4.1 | 12.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
4.0 | 12.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
4.0 | 43.7 | GO:0015643 | toxic substance binding(GO:0015643) |
4.0 | 31.8 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
4.0 | 114.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
3.9 | 19.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
3.8 | 7.7 | GO:0030172 | troponin C binding(GO:0030172) |
3.8 | 15.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
3.8 | 26.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
3.8 | 11.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
3.7 | 15.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
3.7 | 41.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
3.7 | 37.3 | GO:0005272 | sodium channel activity(GO:0005272) |
3.7 | 22.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
3.7 | 7.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
3.7 | 73.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
3.6 | 61.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
3.6 | 7.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
3.6 | 7.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
3.6 | 25.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
3.6 | 32.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
3.6 | 18.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
3.6 | 18.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
3.6 | 7.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
3.6 | 88.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
3.5 | 7.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
3.5 | 35.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
3.5 | 10.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
3.5 | 24.3 | GO:0033691 | sialic acid binding(GO:0033691) |
3.5 | 6.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
3.5 | 3.5 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
3.5 | 27.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
3.4 | 339.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
3.4 | 10.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
3.4 | 10.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
3.4 | 128.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
3.4 | 10.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
3.4 | 13.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
3.3 | 50.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
3.3 | 16.6 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
3.3 | 36.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
3.3 | 16.5 | GO:0043426 | MRF binding(GO:0043426) |
3.3 | 39.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
3.3 | 6.5 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
3.2 | 16.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
3.2 | 6.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
3.2 | 9.5 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
3.2 | 22.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
3.2 | 12.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
3.1 | 9.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
3.1 | 9.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
3.1 | 93.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
3.1 | 3.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
3.1 | 12.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
3.1 | 52.4 | GO:0070888 | E-box binding(GO:0070888) |
3.1 | 6.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
3.1 | 6.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
3.0 | 30.5 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
3.0 | 6.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
3.0 | 66.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
2.9 | 17.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
2.9 | 20.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
2.9 | 40.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
2.9 | 23.0 | GO:0015026 | coreceptor activity(GO:0015026) |
2.9 | 8.6 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
2.8 | 8.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.8 | 13.9 | GO:0046790 | virion binding(GO:0046790) |
2.8 | 8.3 | GO:0042731 | PH domain binding(GO:0042731) |
2.8 | 60.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
2.8 | 38.7 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
2.8 | 35.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
2.8 | 5.5 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
2.7 | 5.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
2.7 | 13.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
2.7 | 5.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
2.7 | 2.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
2.7 | 19.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.7 | 8.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.7 | 26.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
2.7 | 42.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
2.7 | 63.8 | GO:0005109 | frizzled binding(GO:0005109) |
2.6 | 10.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
2.6 | 10.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.6 | 5.1 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
2.5 | 10.2 | GO:0036122 | BMP binding(GO:0036122) |
2.5 | 7.6 | GO:0017166 | vinculin binding(GO:0017166) |
2.5 | 549.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
2.5 | 20.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
2.5 | 5.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
2.5 | 12.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
2.5 | 29.9 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
2.5 | 14.9 | GO:0004629 | phospholipase C activity(GO:0004629) |
2.4 | 134.3 | GO:0019955 | cytokine binding(GO:0019955) |
2.4 | 124.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
2.4 | 7.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
2.3 | 9.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.3 | 7.0 | GO:2001069 | glycogen binding(GO:2001069) |
2.3 | 38.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
2.3 | 15.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
2.3 | 6.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.3 | 22.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
2.3 | 43.0 | GO:0042805 | actinin binding(GO:0042805) |
2.3 | 187.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
2.2 | 11.2 | GO:0031432 | titin binding(GO:0031432) |
2.2 | 9.0 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
2.2 | 42.6 | GO:0050699 | WW domain binding(GO:0050699) |
2.2 | 6.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
2.2 | 17.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
2.2 | 8.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.2 | 30.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
2.2 | 13.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.2 | 21.7 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
2.2 | 6.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
2.2 | 10.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.1 | 8.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.1 | 10.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
2.1 | 6.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.1 | 4.3 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
2.1 | 48.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
2.1 | 4.2 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
2.1 | 96.1 | GO:0017022 | myosin binding(GO:0017022) |
2.1 | 10.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
2.1 | 16.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
2.1 | 2.1 | GO:0051870 | methotrexate binding(GO:0051870) |
2.1 | 6.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
2.1 | 4.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
2.0 | 30.1 | GO:0030276 | clathrin binding(GO:0030276) |
2.0 | 4.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
2.0 | 6.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
2.0 | 92.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
2.0 | 5.9 | GO:0048019 | receptor antagonist activity(GO:0048019) |
1.9 | 9.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
1.9 | 1.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.9 | 7.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.9 | 1.9 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.9 | 17.0 | GO:0030275 | LRR domain binding(GO:0030275) |
1.8 | 24.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
1.8 | 731.7 | GO:0005509 | calcium ion binding(GO:0005509) |
1.8 | 3.6 | GO:0070840 | dynein complex binding(GO:0070840) |
1.8 | 5.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.8 | 17.9 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
1.8 | 14.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
1.8 | 12.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.7 | 56.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
1.7 | 3.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.7 | 6.8 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
1.7 | 20.2 | GO:0032183 | SUMO binding(GO:0032183) |
1.7 | 3.3 | GO:0043199 | sulfate binding(GO:0043199) |
1.7 | 6.6 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.6 | 22.6 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
1.6 | 8.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.6 | 27.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
1.6 | 4.8 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
1.6 | 7.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.6 | 61.6 | GO:0044325 | ion channel binding(GO:0044325) |
1.6 | 7.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.6 | 3.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.6 | 1.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.5 | 6.2 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
1.5 | 377.0 | GO:0003779 | actin binding(GO:0003779) |
1.5 | 6.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.5 | 4.5 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.5 | 3.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.5 | 11.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.5 | 14.7 | GO:0001968 | fibronectin binding(GO:0001968) |
1.5 | 27.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
1.5 | 7.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.4 | 40.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
1.4 | 2.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.4 | 2.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.4 | 35.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
1.4 | 15.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.4 | 11.2 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
1.4 | 7.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.4 | 8.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.4 | 1.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.4 | 1.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.3 | 8.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.3 | 5.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.3 | 9.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.3 | 4.0 | GO:0043495 | protein anchor(GO:0043495) |
1.3 | 1.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.3 | 5.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.3 | 5.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.3 | 10.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.3 | 3.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.2 | 2.4 | GO:0043121 | neurotrophin binding(GO:0043121) |
1.2 | 7.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.2 | 10.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.2 | 5.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.2 | 2.4 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
1.2 | 5.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.2 | 2.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.1 | 35.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
1.1 | 5.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.1 | 14.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.1 | 4.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.1 | 4.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.1 | 1.1 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.1 | 3.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.1 | 8.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.0 | 14.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.0 | 4.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.0 | 19.3 | GO:0030332 | cyclin binding(GO:0030332) |
1.0 | 12.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.0 | 9.0 | GO:0030371 | translation repressor activity(GO:0030371) |
1.0 | 2.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
1.0 | 2.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.0 | 3.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.0 | 11.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.9 | 14.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.9 | 4.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.9 | 68.8 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.9 | 12.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.9 | 2.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.9 | 2.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.9 | 3.4 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.8 | 2.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.8 | 9.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.8 | 13.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.8 | 2.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.8 | 1.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.8 | 0.8 | GO:0031402 | sodium ion binding(GO:0031402) |
0.8 | 2.3 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 4.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.8 | 19.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.8 | 9.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 2.3 | GO:0019862 | IgA binding(GO:0019862) |
0.7 | 8.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.7 | 3.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.7 | 3.5 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.7 | 6.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.7 | 3.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.7 | 1.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.7 | 4.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 1.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.6 | 7.6 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.6 | 3.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.6 | 2.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.6 | 2.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.6 | 267.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.6 | 1.8 | GO:0097001 | ceramide binding(GO:0097001) |
0.6 | 4.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.6 | 3.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.6 | 1.7 | GO:0004096 | catalase activity(GO:0004096) |
0.6 | 31.2 | GO:0008201 | heparin binding(GO:0008201) |
0.6 | 1.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.6 | 2.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.6 | 5.7 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.6 | 5.6 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.5 | 0.5 | GO:0005231 | excitatory extracellular ligand-gated ion channel activity(GO:0005231) |
0.5 | 1.6 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.5 | 5.4 | GO:0044653 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.5 | 3.7 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.5 | 1.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.5 | 1.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 1.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.5 | 12.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.5 | 1.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.5 | 1.4 | GO:0002046 | opsin binding(GO:0002046) |
0.5 | 3.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.5 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 10.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.4 | 1.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.4 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.4 | 1.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.4 | 1.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 1.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.4 | 0.8 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.4 | 1.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.4 | 7.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.4 | 1.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.4 | 6.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 1.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 0.4 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 5.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.3 | 3.7 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 4.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 1.8 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 4.2 | GO:0003774 | motor activity(GO:0003774) |
0.3 | 3.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.3 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 0.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 0.5 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.2 | 5.2 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 2.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 1.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 0.2 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 2.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 10.9 | GO:0060090 | binding, bridging(GO:0060090) |
0.2 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.8 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.2 | 5.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 4.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 3.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 25.1 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.2 | GO:0016160 | amylase activity(GO:0016160) |
0.0 | 5.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.0 | 22.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
9.7 | 309.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
8.0 | 104.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
7.8 | 7.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
7.7 | 192.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
7.5 | 59.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
7.0 | 125.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
6.8 | 102.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
6.8 | 292.5 | NABA COLLAGENS | Genes encoding collagen proteins |
6.5 | 71.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
6.3 | 202.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
6.2 | 99.7 | PID REELIN PATHWAY | Reelin signaling pathway |
6.2 | 74.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
6.0 | 71.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
5.6 | 144.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
5.6 | 22.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
5.4 | 16.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
5.3 | 37.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
5.1 | 41.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
5.0 | 169.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
4.9 | 107.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
4.9 | 126.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
4.7 | 14.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
4.7 | 14.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
4.5 | 154.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
4.2 | 67.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
4.1 | 672.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
4.0 | 56.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
3.9 | 73.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
3.8 | 57.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
3.7 | 37.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
3.6 | 118.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
3.6 | 131.5 | PID BMP PATHWAY | BMP receptor signaling |
3.4 | 106.9 | PID FGF PATHWAY | FGF signaling pathway |
3.4 | 44.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
3.4 | 84.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
3.2 | 3.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
3.0 | 24.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
3.0 | 47.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
2.9 | 2.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.7 | 19.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
2.7 | 45.2 | PID RAS PATHWAY | Regulation of Ras family activation |
2.6 | 343.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
2.4 | 2.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.2 | 8.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.2 | 57.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
2.1 | 44.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
2.1 | 10.5 | PID ALK2 PATHWAY | ALK2 signaling events |
2.0 | 483.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
2.0 | 11.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.0 | 43.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
1.9 | 385.6 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
1.9 | 7.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.8 | 16.6 | PID ENDOTHELIN PATHWAY | Endothelins |
1.8 | 7.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.8 | 5.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.7 | 56.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
1.7 | 11.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.7 | 31.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.6 | 4.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.6 | 4.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.4 | 8.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.3 | 4.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.3 | 11.6 | PID INSULIN PATHWAY | Insulin Pathway |
1.2 | 10.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.2 | 18.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.1 | 8.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.1 | 8.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.1 | 11.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
1.1 | 15.1 | PID AURORA A PATHWAY | Aurora A signaling |
1.0 | 10.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.0 | 57.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.9 | 8.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.8 | 17.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.8 | 21.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.7 | 19.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 3.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 14.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 13.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.6 | 9.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.6 | 5.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 4.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.5 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.5 | 1.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 3.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 4.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 9.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 4.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 9.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 1.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 2.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 2.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.2 | 25.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
19.4 | 232.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
17.7 | 264.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
15.2 | 213.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
13.9 | 195.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
13.4 | 40.3 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
13.1 | 13.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
12.3 | 208.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
12.1 | 520.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
11.7 | 105.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
11.6 | 302.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
11.2 | 437.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
10.0 | 229.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
9.9 | 29.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
9.7 | 77.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
9.6 | 106.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
9.3 | 83.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
9.2 | 9.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
9.1 | 99.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
8.8 | 26.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
8.7 | 78.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
8.6 | 103.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
8.6 | 198.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
8.2 | 98.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
8.2 | 188.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
8.0 | 16.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
6.8 | 246.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
6.7 | 26.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
6.3 | 120.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
6.3 | 18.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
6.1 | 97.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
5.9 | 146.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
5.7 | 74.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
5.5 | 201.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
5.4 | 27.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
5.4 | 119.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
5.2 | 72.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
4.8 | 52.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
4.8 | 4.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
4.8 | 80.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
4.6 | 59.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
4.5 | 22.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
4.4 | 80.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
4.4 | 35.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
4.3 | 80.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
4.2 | 50.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
4.2 | 33.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
4.2 | 16.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
4.1 | 24.5 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
4.0 | 64.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
4.0 | 36.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
4.0 | 43.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
3.9 | 27.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
3.7 | 7.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
3.7 | 29.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
3.7 | 3.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
3.7 | 47.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
3.6 | 32.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
3.5 | 98.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
3.4 | 44.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
3.4 | 41.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
3.4 | 47.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
3.3 | 26.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
3.3 | 35.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
3.3 | 22.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
3.2 | 51.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
3.1 | 18.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
3.0 | 50.4 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
2.9 | 20.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.9 | 14.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
2.8 | 11.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
2.8 | 180.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
2.7 | 5.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
2.7 | 32.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
2.6 | 5.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
2.6 | 26.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.6 | 7.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
2.5 | 56.0 | REACTOME KINESINS | Genes involved in Kinesins |
2.5 | 10.0 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
2.5 | 12.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
2.5 | 64.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
2.4 | 4.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
2.4 | 7.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
2.1 | 12.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
2.1 | 46.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
2.1 | 33.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
2.1 | 14.6 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
2.0 | 2.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
2.0 | 22.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
2.0 | 16.1 | REACTOME OPSINS | Genes involved in Opsins |
2.0 | 56.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
2.0 | 20.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
2.0 | 2.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
2.0 | 49.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
1.9 | 60.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.8 | 1.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.8 | 3.7 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
1.8 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
1.8 | 5.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.7 | 28.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.7 | 37.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
1.7 | 11.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.7 | 38.4 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
1.6 | 22.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
1.6 | 17.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.6 | 14.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.6 | 14.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.5 | 15.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.4 | 4.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.3 | 10.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.3 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
1.3 | 19.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
1.2 | 13.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.2 | 39.9 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
1.2 | 17.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.2 | 8.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.2 | 6.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.1 | 15.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.1 | 16.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
1.1 | 17.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.9 | 11.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.9 | 25.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.9 | 80.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.8 | 1.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.8 | 7.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.8 | 4.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.8 | 7.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.8 | 8.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.8 | 3.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.7 | 0.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.7 | 15.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.6 | 13.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 9.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.5 | 42.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.5 | 29.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 1.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 6.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.4 | 2.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 6.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.2 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 1.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |